证券代码：688757 证券简称：胜科纳米 公告编号：2025-032 胜科纳米（苏州）股份有限公司 2025年半年度权益分派实施公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： | 股权登记日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | | 2025/11/6 | 2025/11/7 | 2025/11/7 | 一、 通过分配方案的股东会届次和日期 本次利润分配方案经公司2025 年 9 月 12 日的2025年第二次临时股东会审议通 过。 二、 分配方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 是否涉及差异化分红送转：否 每股分配比例 每股现金红利0.05元（含税） 相关日期 1. 发放年度：2025年半年度 2. 分派对象： 3. 分配方案： 本次利润分配以方案实施前的公司总股本403,311,486股为基数，每股派发现 金红利0.05元（含税），共计派发现金 ...

Core Viewpoint - The company, Shengke Nano (Suzhou) Co., Ltd., has released its quarterly report, ensuring the accuracy and completeness of the financial information presented, and confirming that there are no false records or significant omissions [2][3]. Financial Data Summary - The financial statements for the third quarter are unaudited, covering the period from the beginning to the end of the quarter [3][5]. - The report includes major accounting data and financial indicators, although specific figures are not detailed in the provided text [3][5]. - The company has not identified any non-recurring gains or losses that are significant enough to warrant special mention [3][4]. Shareholder Information - There is no change in the number of shareholders or significant shareholders compared to the previous period, and no participation in securities lending activities has been reported [4][5]. Other Important Information - The company has not indicated any additional important information regarding its operational status during the reporting period [5]. - The financial statements, including the consolidated balance sheet and cash flow statement, are prepared under the new accounting standards but are not audited [6][7].

Core Viewpoint - Shengke Nano (688757.SH) reported a significant increase in revenue and net profit for the first three quarters of 2025, indicating strong business performance and growth potential [1] Financial Performance - The company achieved total operating revenue of 386 million yuan, representing a year-on-year growth of 31.22% [1] - The net profit attributable to shareholders reached 56.59 million yuan, showing a year-on-year increase of 3.59% [1] - Basic earnings per share were reported at 0.15 yuan [1]

Core Insights - The company reported a revenue of 385,845,103.24 yuan for the first three quarters of 2025, representing a year-on-year growth of 31.22% [2] - The net profit attributable to shareholders of the listed company was 56,586,865.80 yuan, showing a year-on-year increase of 3.59% [2] Financial Performance - Revenue for the first three quarters of 2025: 385.85 million yuan, up 31.22% year-on-year [2] - Net profit for the same period: 56.59 million yuan, up 3.59% year-on-year [2]

Financial Performance - The company's operating revenue for Q3 2025 was ¥146,604,936.43, representing a year-on-year increase of 34.97%[3] - The total profit for the quarter was ¥22,662,651.04, showing a decrease of 17.94% compared to the same period last year[3] - Net profit attributable to shareholders was ¥23,218,225.61, down 5.98% year-on-year[3] - Total operating revenue for the first three quarters of 2025 reached ¥385,845,103.24, a 31.2% increase from ¥294,041,286.40 in the same period of 2024[18] - Net profit for the first three quarters of 2025 was ¥56,586,865.80, compared to ¥54,627,824.73 in 2024, reflecting a 3.6% increase[19] Assets and Liabilities - The total assets at the end of the reporting period reached ¥1,788,934,867.36, an increase of 19.89% from the end of the previous year[4] - Total liabilities amounted to ¥886,448,664.01, slightly up from ¥886,139,338.63 in 2024, indicating stable financial leverage[16] - The total assets of the company as of the end of the reporting period were ¥1,788,934,867.36, compared to ¥1,492,105,289.02 in the previous year, marking a growth of 19.9%[16] Shareholder Information - The company reported a total of 9,036 common shareholders at the end of the reporting period[10] - The largest shareholder, Li Xiaomin, holds 39.41% of the shares, totaling 158,937,232 shares[10] - The second-largest shareholder, Ningbo Fengnian Rongtong Investment Management, holds 6.22% with 25,071,347 shares[10] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥155,814,159.05, reflecting a slight increase of 0.33%[3] - The cash flow from operating activities for the first three quarters of 2025 was ¥375,254,916.37, compared to ¥296,966,975.33 in 2024, showing a strong cash generation capability[22] - Operating cash inflow totaled $404,639,874.82, an increase from $342,667,241.77 in the previous period, reflecting a growth of approximately 18.1%[23] Research and Development - Research and development expenses totaled ¥14,064,097.85, accounting for 9.59% of operating revenue, a decrease of 0.62 percentage points[4] - Research and development expenses increased to ¥41,023,247.28 in 2025, up from ¥32,643,817.33 in 2024, indicating a focus on innovation[19] Equity - The equity attributable to shareholders increased by 48.93% to ¥902,486,203.35 due to the completion of the initial public offering[8] - The company's equity attributable to shareholders increased to ¥902,486,203.35 from ¥605,965,950.39, representing a significant growth of 48.9%[16] Cash and Cash Equivalents - Cash and cash equivalents rose to ¥133,815,605.65, compared to ¥112,620,868.69 at the end of 2024, indicating an increase of about 18.8%[14] - The total cash and cash equivalents at the end of the period amounted to $133,815,605.65, compared to $111,830,341.13 at the end of the previous period, showing an increase of approximately 19.6%[24] Investment Activities - Net cash outflow from investing activities was -$388,173,960.76, compared to -$332,514,204.00 in the prior period, indicating a decline in investment cash flow[23] - Cash paid for the purchase of fixed assets was $350,838,173.51, slightly down from $353,196,885.67, indicating a decrease of about 0.8%[23] Future Outlook - The company plans to implement new accounting standards starting in 2025, which may affect financial reporting[25]

Market Overview - The professional services sector increased by 0.83% on the previous trading day, with Anche Detection leading the gains [1] - The Shanghai Composite Index closed at 3996.94, up by 1.18%, while the Shenzhen Component Index closed at 13489.4, up by 1.51% [1] Top Performers - Anche Detection (300572) closed at 32.72, with a rise of 7.45% and a trading volume of 181,700 shares, totaling a transaction value of 591 million yuan [1] - Shengke Nano (688757) closed at 31.05, up by 6.70%, with a trading volume of 51,100 shares and a transaction value of 158 million yuan [1] - Gangyan Nake (300797) closed at 18.36, increasing by 6.62%, with a trading volume of 209,300 shares and a transaction value of 379 million yuan [1] Underperformers - Shishi Testing (300416) closed at 16.02, down by 3.73%, with a trading volume of 330,800 shares and a transaction value of 532 million yuan [2] - Guangdong Jianke (301632) closed at 29.59, decreasing by 2.08%, with a trading volume of 75,100 shares and a transaction value of 222 million yuan [2] - Xince Standard (300938) closed at 26.55, down by 1.96%, with a trading volume of 143,300 shares and a transaction value of 389 million yuan [2] Capital Flow - The professional services sector experienced a net outflow of 202 million yuan from institutional investors, while retail investors saw a net inflow of 122 million yuan [2] - The sector's overall capital flow indicates a mixed sentiment, with institutional investors withdrawing funds while retail investors are actively buying [2] Individual Stock Capital Flow - Anche Detection (301289) had a net inflow of 25.6 million yuan from institutional investors, while it faced a net outflow of 21.6 million yuan from retail investors [3] - Gangyan Nake (300797) saw a net inflow of 13.6 million yuan from institutional investors and a net inflow of 15.1 million yuan from speculative investors [3] - Zhonggang Tianyuan (002057) had a net inflow of 7.4 million yuan from institutional investors, while retail investors experienced a net outflow of 11.3 million yuan [3]

Group 1 - The core point of the article highlights the fundraising activities of companies listed on the STAR Market, with a total of 10 companies raising 16.736 billion yuan this year, averaging 1.674 billion yuan per company [1][2] - Xi'an Yicai leads in fundraising with 4.636 billion yuan, primarily for the second phase of its silicon industry base project [1] - He Yuan Bio follows with 2.599 billion yuan raised for the construction of a plant-based recombinant human serum albumin production base and other projects [1] Group 2 - The average initial offering price of STAR Market stocks this year is 20.76 yuan, with the highest being 47.27 yuan for Ying Shi Innovation [1][2] - The issuance price of Xi'an Yicai and Yitang shares is relatively low at 8.62 yuan and 8.45 yuan respectively [1] - The issued price-earnings ratios range from 6.14 to 51.55, with an average of 30.03 and a median of 26.35 [2] Group 3 - The majority of the newly issued STAR Market companies are concentrated in Jiangsu, Hubei, and Guangdong provinces, each with two companies [2] - The top fundraising regions are Shaanxi, Hubei, and Guangdong, with amounts of 4.636 billion yuan, 3.767 billion yuan, and 3.538 billion yuan respectively [2] - Two companies have issuance price-earnings ratios above the industry average, while five companies are below it [2]

Core Insights - The total amount raised by companies on the STAR Market this year has reached 15.136 billion yuan, with an average fundraising of 1.682 billion yuan per company [1][2] - The highest fundraising company is Xian Yicai, which raised 4.636 billion yuan, primarily for its silicon industry base project [1] - The average initial offering price for STAR Market stocks this year is 21.09 yuan, with the highest being 47.27 yuan for Ying Shi Innovation [1][2] Fundraising Overview - A total of 9 companies have issued new shares on the STAR Market this year, with 5 companies raising over 1 billion yuan and 3 companies raising between 500 million to 1 billion yuan [1] - The companies with significant fundraising include: - Xian Yicai: 4.636 billion yuan - He Yuan Biological: 2.599 billion yuan - Yi Tang Co.: 2.497 billion yuan - Ying Shi Innovation: 1.938 billion yuan - Xing Fu Electronics: 1.168 billion yuan [1] Pricing and Valuation - The average issuance price for STAR Market stocks is 21.09 yuan, with the highest price at 47.27 yuan for Ying Shi Innovation and the lowest at 8.45 yuan for Yi Tang Co. [1] - The issuance price-to-earnings (P/E) ratio ranges from 6.14 to 51.55, with an average of 30.03 and a median of 26.35 [2] - Yi Tang Co. has the highest P/E ratio at 51.55, while several companies have P/E ratios below the industry average [2] Regional Distribution - The majority of the companies issued this year are concentrated in Beijing, Jiangsu, and Hubei, with each region having 2 companies [2] - The top fundraising regions are Shaanxi, Hubei, and Beijing, with amounts of 4.636 billion yuan, 3.767 billion yuan, and 3.359 billion yuan respectively [2]

Summary of Key Points Core Viewpoint - In 2023, a total of 8 companies have issued new shares on the Sci-Tech Innovation Board, raising a cumulative amount of 10.5 billion yuan, with an average fundraising of 1.313 billion yuan per company [1][2]. Fundraising Overview - The fundraising amounts are categorized as follows: 4 companies raised over 1 billion yuan, 3 companies raised between 500 million yuan and 1 billion yuan, and 1 company raised less than 500 million yuan [1]. - The company with the highest fundraising is He Yuan Biological, which raised 2.599 billion yuan primarily for the construction of a plant-based recombinant human serum albumin industrialization base, working capital, and new drug research and development [1]. - Following He Yuan Biological, Yitang Co., Ltd. raised 2.497 billion yuan for technology reserve funds and semiconductor high-end integrated circuit equipment R&D projects [1]. Issuance Price and Valuation - The average issuance price of the newly listed Sci-Tech Innovation Board stocks is 22.64 yuan, with the highest being 47.27 yuan for Yingshi Innovation [2]. - The issuance price for He Yuan Biological and Sikan Technology is 29.06 yuan and 33.46 yuan, respectively, while Yitang Co., Ltd. has the lowest issuance price at 8.45 yuan [1][2]. Price-to-Earnings Ratio - The issued companies have a price-to-earnings (P/E) ratio ranging from 6.14 to 51.55, with an average of 30.03 and a median of 26.35 [2]. - Yitang Co., Ltd. has the highest P/E ratio at 51.55, while five companies, including Yingshi Innovation and Sikan Technology, have P/E ratios below the industry average [2]. Regional Distribution - The newly issued companies are primarily located in Beijing, Jiangsu, and Hubei, each having 2 companies [2]. - The regions with the highest fundraising amounts are Hubei (3.767 billion yuan), Beijing (3.359 billion yuan), and Guangdong (1.938 billion yuan) [2].

Group 1 - The core viewpoint of the news highlights the trading performance and financial metrics of Shengke Nano, indicating a slight increase in stock price and a net financing outflow on October 13 [1] - On October 13, Shengke Nano's stock price rose by 0.10%, with a trading volume of 73.20 million yuan, and a net financing buy of -1.41 million yuan [1] - As of October 13, the total margin balance for Shengke Nano was 117 million yuan, accounting for 10.84% of its market capitalization [1] Group 2 - As of June 30, the number of shareholders for Shengke Nano was 11,300, a decrease of 29.30% from the previous period, while the average circulating shares per person increased by 41.45% to 2,891 shares [2] - For the first half of 2025, Shengke Nano reported a revenue of 239 million yuan, representing a year-on-year growth of 29.03%, and a net profit attributable to shareholders of 33.37 million yuan, up 11.48% year-on-year [2] - Since its A-share listing, Shengke Nano has distributed a total of 60.09 million yuan in dividends [2]